Therefore, the aim of our work was to summarize the available literature on APRIL and its involvement in colorectal cancer carcinogenesis, as well as its utility as a possible biomarker and therapeutic target in colorectal cancer. The gene discussed is TNFSF13; the disease is colorectal cancer.